Document is current
Any future updates will be listed below
-
Authors
Shi, Jing-Ru
Poulard, Coralie
Cerutti, Catherine
Trédan, Olivier
Le Romancer, Muriel
Shi, Tie-Liu
Vanacker, Jean-Marc
-
Funding
Funding for this research was provided by:
Chinese Scholarship Council, China
Ligue Contre le Cancer
Joriss/ENS research program
- License Information
-
More Information
Article History
Received: 8 January 2026
Accepted: 15 April 2026
First Online: 8 May 2026
Declarations
:
: Not applicable.
: Not applicable.
: OT received honoraria for lectures, presentations, and advisory board from Roche, Pfizer, Novartis-Sandoz, Lilly, MSD, Astra-Zeneca, Pierre Fabre, Seagen, Daiichi-Sankyo, Gilead, Eisai, Menarini-Stemline, Veracyte and Exact Sciences. Funders had no role in the design of the study, collection and analysis of data and decision to publish.
